NDC properties for NDC 9 51759-402
NDC item 51759040202
| NDC 9 | 51759-402 |
|---|---|
| NDC 10 | 51759-402-02 |
| NDC Item | 51759040202 |
| packaging | 2 KIT in 1 CARTON (51759-402-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-20 |
| Marketing status | ACTIVE |
NDC item 51759040217
| NDC 9 | 51759-402 |
|---|---|
| NDC 10 | 51759-402-17 |
| NDC Item | 51759040217 |
| packaging | 1 KIT in 1 CARTON (51759-402-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-20 |
| Marketing status | ACTIVE |
NDC item 51759051321
| NDC 9 | 51759-513 |
|---|---|
| NDC 10 | 51759-513-21 |
| NDC Item | 51759051321 |
| packaging | 0.4 mL in 1 SYRINGE |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |